Chromatin XXXX changes in cell proliferation and/or apoptosis induced by @entity17544 .

@entity2310 @entity25993 @entity2367 @entity17544 @entity35 @entity4291
It has been shown that @entity25993 and @entity4291 -synthase activities are present in chromatin and they modify the @entity4291 (SM) content. The activity of the first enzyme is stimulated and the second inhibited, when the hepatocytes enter into the S-phase after partial hepatectomy, thus suggesting that @entity2367 may have a pivotal role in cell proliferation. An opposite function was attributed to @entity2367 in hepatocytes which undergo apoptosis after lobular ligature. In order to clarify this point, a model was developed in which the same liver cells undergo proliferation followed by induced apoptosis. To this purpose, the @entity35 were treated for 7 days with @entity17544 and then left without treatment for 4 days. During the treatment, the peroxisome enzyme markers increase their activity and the number of proliferating cells increases, reaching a maximum after 3 days of treatment, as shown by the number of cells positive for the proliferating cell nuclear antigen. At the same time, the chromatin sphingomyelinase activity reaches the maximum, while a similar increase is not found in the cytoplasm or in the isolated nuclei. On the contrary, SM-synthase activity is depressed in chromatin, but not in the nuclei in which a peak is shown after 3 days of @entity17544 treatment. After drug withdrawal, the hepatocytes undergo apoptosis as confirmed by the increase of @entity2310 and tissue transglutaminase (tTGase) expression; the chromatin SM increases as a consequence of an increase of SM-synthase activity. It can be hypothesised that chromatin SM may have a role in cell duplication by influencing the chromatin structure stability.
